Regeneron Pharmaceuticals (REGN)
Operating Cash Flow
$574.50M
Quarterly · Period ending: · USD
REGN Operating Cash Flow
Latest reported$574.50Mperiod ending
Latest reported$574.50Mperiod ending
REGN Quarterly Operating Cash Flow (-$2.70M → $574.50M)
Quarterly operating cash flow
High-resolution chart · PNG
REGN operating cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -9,378,000 | |
| -8,397,000 | |
| -3,770,000 | |
| -4,204,000 | |
| -3,349,000 | |
| -16,587,000 | |
| 7,000,000 | |
| -7,700,000 | |
| -4,700,000 | |
| -8,400,000 | |
| -5,700,000 | |
| 4,200,000 | |
| -4,500,000 | |
| -4,200,000 | |
| 3,100,000 | |
| -1,700,000 | |
| -4,100,000 | |
| -3,400,000 | |
| -100,000 | |
| -7,000,000 | |
| -5,900,000 | |
| -7,300,000 | |
| 2,100,000 | |
| -11,300,000 | |
| -2,400,000 | |
| -6,600,000 | |
| -11,400,000 | |
| -5,900,000 | |
| 5,800,000 | |
| -9,000,000 | |
| -9,000,000 | |
| -6,000,000 | |
| -7,800,000 | |
| -7,300,000 | |
| -6,000,000 | |
| -3,800,000 | |
| -4,200,000 | |
| -3,200,000 | |
| -1,400,000 | |
| -2,700,000 |